Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MOLECULAR-WEIGHT HEPARINS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 135 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Samdani, S; Lachmann, E; Nagler, W
      Unilateral extremity swelling in female patients with cancer

      JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
    2. Lopez-Sendon, J
      Coronary reperfusion in the clinical setting: antithrombotic support to thrombolysis in the coronary care unit

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    3. Kelly, J; Rudd, A; Lewis, RR; Hunt, BJ
      Screening for subclinical deep-vein thrombosis

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    4. Turton, EPL; Coughlin, PA; Berridge, DC; Mercer, KG
      A survey of deep venous thrombosis management by consultant vascular surgeons in the United Kingdom and Ireland

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    5. Grassegger, A; Fritsch, P; Reider, N
      Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: A prospective study

      DERMATOLOGIC SURGERY
    6. Porras, MC; Bonilla, BC; Gomez, EP; Ruiz, MG
      Dalteparin-induced extremity hematoma complicated by probable compartment syndrome

      ANNALS OF PHARMACOTHERAPY
    7. Porras, MC; Martin, MD; Ruiz, MG
      Dalteparin-induced retroperitoneal bleeding

      ANNALS OF PHARMACOTHERAPY
    8. Uflacker, R
      Interventional therapy for pulmonary embolism

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    9. Merli, GJ; Vanscoy, GJ; Rihn, TL; Groce, JB; McCormick, W
      Applying scientific criteria to therapeutic interchange: A balanced analysis of low-molecular-weight heparins

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    10. Cohen, M
      The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    11. Smith, BS; Gandhi, PJ
      Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins andglycoprotein IIb/IIIa receptor antagonists in renal failure

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    12. Belmin, J; Medjahed, S; Trivalle, C; Lutzer, P
      Heparin use and risk patterns in geriatric patients: a one-day audit in France

      PRESSE MEDICALE
    13. Pastores, SM
      Acute respiratory failure in critically ill patients with cancer - Diagnosis and management

      CRITICAL CARE CLINICS
    14. Batchelor, WB; Mahaffey, KW; Berger, PB; Deutsch, E; Meier, S; Hasselblad, V; Fry, ET; Teirstein, PS; Ross, AM; Binanay, CA; Zidar, JP
      A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    15. Brown, DFM
      Treatment options for deep venous thrombosis

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    16. Huber, K; Niessner, A; Niessner, H
      Low molecular weight heparins in acute coronary syndrome

      HERZ
    17. Franco, A
      Low molecular weight heparins and hemorrhagic risk in elderly patients

      REVUE DE MEDECINE INTERNE
    18. Pautas, E; Siguret, V; d'Urso, M; Laurent, M; Gaussem, P; Fevrier, M; Durand-Gasselin, B
      Monitoring of tinzaparin treatment at treatment dose of 10 days in elderlypatients

      REVUE DE MEDECINE INTERNE
    19. Figarella, I; Barbaud, A; Lecompte, T; De Maistre, E; Reichert-Penetrat, S; Schmutz, JL
      Cutaneous delayed hypersensitivity reactions to heparins and heparinoids.

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    20. Nader, HB; Pinhal, MAS; Bau, EC; Castro, RAB; Medeiros, GF; Chavante, SF; Leite, EL; Trindade, ES; Shinjo, SK; Rocha, HAO; Tersariol, ILS; Mendes, A; Dietrich, CP
      Development of new heparin-like compounds and other antithrombotic drugs and their interaction with vascular endothelial cells

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    21. Varki, A; Varki, NM
      P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    22. Guerrini, M; Bisio, A; Torri, G
      Combined quantitative H-1 and C-13 nuclear magnetic resonance spectroscopyfor characterization of heparin preparations

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    23. Riess, H; Loew, A; Himmelreich, G
      Secondary osteoporosis induced by anticoagulant drugs?

      ORTHOPADE
    24. Goldhaber, SZ
      Unsolved issues in the treatment of pulmonary embolism

      THROMBOSIS RESEARCH
    25. Hofmann, S; Knoefler, R; Lorenz, N; Siegert, G; Wendisch, J; Mueller, D; Taut-Sack, H; Dinger, J; Kabus, M
      Clinical experiences with low-molecular weight heparins in pediatric patients

      THROMBOSIS RESEARCH
    26. Ahmad, S; Jeske, WP; Ma, Q; Walenga, JM; Fareed, J
      Inhibition of tissue factor-activated platelets by low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonist

      THROMBOSIS RESEARCH
    27. Klein-Weigel, P; Fraedrich, G
      Conservative treatment of acute deep vein thrombosis of the lower extremity

      ZENTRALBLATT FUR CHIRURGIE
    28. Mary, V; Wahl, F; Uzan, A; Stutzmann, JM
      Enoxaparin in experimental stroke - Neuroprotection and therapeutic windowof opportunity

      STROKE
    29. Kelly, J; Rudd, A; Lewis, R; Hunt, BJ
      Venous thromboembolism after acute stroke

      STROKE
    30. Taraktchoglou, M; Pacey, AA; Turnbull, JE; Eley, A
      Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent onhost cell heparan sulfate

      INFECTION AND IMMUNITY
    31. Hamel, E; Pacouret, G; Vincentelli, D; Forissier, JF; Peycher, P; Pottier, JM; Charbonnier, B
      Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation - Results from a 128-patient monocenter registry

      CHEST
    32. Ruiz-Calero, V; Puignou, L; Diez, M; Galceran, MT
      Determination of free and total sulfate and phosphate in glycosaminoglycans by column-switching high-performance size-exclusion and ion chromatography and single-column ion chromatography

      ANALYST
    33. Kereiakes, DJ; Kleiman, NS; Fry, E; Mwawasi, G; Lengerich, R; Maresh, K; Burkert, ML; Aquilina, JW; DeLoof, M; Broderick, TM; Shimshak, TM
      Dalteparin in combination with abciximab during percutaneous coronary intervention

      AMERICAN HEART JOURNAL
    34. von Tempelhoff, GF; Nieman, F; Heilmann, L; Hommel, G
      Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy

      CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
    35. Wallentin, L
      Low molecular weight heparin in unstable coronary artery disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    36. Ahsan, A; Jeske, W; Wolf, H; Fareed, J
      Isoamyl nitrite depolymerized heparin as a universal calibrator for heparins and low molecular weight heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    37. Planes, A
      Prevention of deep vein thrombosis after hip replacement - Reply

      THROMBOSIS AND HAEMOSTASIS
    38. Turpie, AGG
      Can we differentiate the low-molecular-weight heparins?

      CLINICAL CARDIOLOGY
    39. Wallentin, L
      Long-term management - The way forward?

      CLINICAL CARDIOLOGY
    40. Enrique, E; Alijotas, J; Cistero, A; san Miguel, MM; Bartra, J; Tresserra, F
      Patch-test positivity in cutaneous reactions to enoxaparin

      CONTACT DERMATITIS
    41. Samama, MM; Gerotziafas, GT
      Comparative pharmacokinetics of LMWHs

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    42. Breddin, HK
      Prophylaxis and treatment of deep-vein thrombosis

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    43. Zacharski, LR; Ornstein, DL; Mamourian, AC
      Low-molecular-weight heparin and cancer

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    44. Yee, JYV; Duffull, SB
      The effect of body weight on dalteparin pharmacokinetics - A preliminary study

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    45. Nugent, MA
      Heparin sequencing brings structure to the function of complex oligosaccharides

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    46. Borja, J; Olivella, P
      Low molecular weigh heparin in the treatment of acute coronary syndromes without ST elevation: unstable angina and non Q wave myocardial infaction

      MEDICINA CLINICA
    47. Chaves, CJ; Caplan, LR
      Heparin and oral anticoagulants in the treatment of brain ischemia

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    48. Makris, M; Hough, RE; Kitchen, S
      Poor reversal of low molecular weight heparin by protamine

      BRITISH JOURNAL OF HAEMATOLOGY
    49. Fabris, F; Ahmad, S; Cella, G; Jeske, WP; Walenga, JM; Fareed, J
      Pathophysiology of heparin-induced thrombocytopenia clinical and diagnostic implications - A review

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    50. Granger, CB
      Strategies at patient care in acute coronary syndromes: Rationale for the Global Registry of Acute Coronary Events (GRACE) Registry

      AMERICAN JOURNAL OF CARDIOLOGY
    51. Ahmad, S; Jeske, WP; Walenga, JM; Hoppensteadt, DA; Wood, JJ; Herbert, JM; Messmore, HL; Fareed, J
      Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    52. Mammen, EF
      Low molecular weight heparins and heparin-induced thrombocytopenia

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    53. Peek, GJ; Firmin, RK
      The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation

      ASAIO JOURNAL
    54. Haas, S
      Limitations of established antithrombotic strategies

      BLOOD COAGULATION & FIBRINOLYSIS
    55. Agnelli, G; Taliani, MR; Verso, M
      Building effective prophylaxis of deep vein thrombosis in the outpatient setting

      BLOOD COAGULATION & FIBRINOLYSIS
    56. Lassen, MR; Borris, LC; Backs, S; Kaltoft-Sorensen, M; Coff-Ganes, H; Jeppesen, E
      Clinical limitations of risk assessment models

      BLOOD COAGULATION & FIBRINOLYSIS
    57. Gallus, AS
      Applying risk assessment models in orthopaedic surgery: overview of our clinical experience

      BLOOD COAGULATION & FIBRINOLYSIS
    58. Ageno, W
      Applying risk assessment models in general surgery: overview of our clinical experience

      BLOOD COAGULATION & FIBRINOLYSIS
    59. Samama, MM
      Applying risk assessment models in general surgery: effective risk stratification

      BLOOD COAGULATION & FIBRINOLYSIS
    60. Piovella, F; Barone, M
      Long-term management of deep vein thrombosis

      BLOOD COAGULATION & FIBRINOLYSIS
    61. Saltissi, D; Morgan, C; Westhuyzen, J; Healy, H
      Comparison of low-molecular-weight heparin (enoxaparin sodium) and standard unfractionated heparin for haemodialysis anticoagulation

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    62. Vanscoy, GJ
      Outpatient management of venous thromboembolism

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    63. Bauld, DL; Kovacs, MJ
      Dalteparin in emergency patients to prevent admission prior to investigation for venous thromboembolism

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    64. Grossman, C; McPherson, S
      Safety and efficacy of catheter-directed thrombolysis for iliofemoral venous thrombosis

      AMERICAN JOURNAL OF ROENTGENOLOGY
    65. Beguin, S; Welzel, D; Al Dieri, R; Hemker, HC
      Conjectures and refutations on the mode of action of heparins - The limited importance of anti-factor Xa activity as a pharmaceutical mechanism and ayardstick for therapy

      HAEMOSTASIS
    66. Wallentin, L
      Low-molecular-weight heparins in coronary thrombosis: Today and tomorrow

      HAEMOSTASIS
    67. Roy, S; Brosstad, F; Sakariassen, KS
      Selective thrombolysis in acute deep vein thrombosis: Evaluation of adjuvant therapy in vivo

      CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
    68. Lamy, O; Cornuz, J; Yersin, B
      Subcutaneous low molecular weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis: a systematic review

      SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT
    69. Fletcher, JP; McLellan, D; Cade, J; Fisher, C; Gibbs, H; Stacey, M; Vedig, A
      Prevention of venous thrombo-embolism

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY
    70. Ramamurthy, N; Baliga, N; Wakefield, TW; Andrews, PC; Yang, VC; Meyerhoff, ME
      Determination of low-molecular-weight heparins and their binding to protamine and a protamine analog using polyion-sensitive membrane electrodes

      ANALYTICAL BIOCHEMISTRY
    71. Spandorfer, JM; Lynch, S; Weitz, HH; Fertel, S; Merli, GJ
      Use of Enoxaparin for the chronically anticoagulated patient before and after procedures

      AMERICAN JOURNAL OF CARDIOLOGY
    72. STREKERUD FG; ABILDGAARD U
      HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN PROLONG PROTHROMBIN TIMES INPATIENTS ON WARFARIN TREATMENT

      Clinical and applied thrombosis/hemostasis
    73. MARTINEAU P; TAWIL N
      LOW-MOLECULAR-WEIGHT HEPARINS IN THE TREATMENT OF DEEP-VEIN THROMBOSIS

      The Annals of pharmacotherapy
    74. SANTAMARIA A; ROMANI J; SOUTO JC; LOPEZ A; MATEO J; FONTCUBERTA J
      SKIN NECROSIS AT THE INJECTION SITE INDUCED BY LOW-MOLECULAR-WEIGHT HEPARIN - CASE-REPORT AND REVIEW

      Dermatology
    75. KAUW FHW; CLEOPHAS TJM; KALMANSOHN RB
      LOW-MOLECULAR-WEIGHT HEPARINS BETTER THAN UNFRACTIONATED HEPARIN IN UNSTABLE CORONARY-ARTERY DISEASE - UNSTABLE ANGINA-PECTORIS NON-Q-WAVE INFARCTION A PARTLY OUTPATIENT-CLINIC CONDITION

      International journal of clinical pharmacology and therapeutics
    76. Meschia, JF
      Anticoagulant and defibrinogenating agents in acute ischemic stroke and cerebral venous thrombosis

      SEMINARS IN NEUROLOGY
    77. PURCELL H; FOX KM
      CURRENT ROLES AND FUTURE POSSIBILITIES FOR LOW-MOLECULAR-WEIGHT HEPARINS IN UNSTABLE ANGINA

      European heart journal
    78. AGNELLI G; SONAGLIA F
      ANTICOAGULANT AGENTS IN THE MANAGEMENT OF PULMONARY-EMBOLISM

      International journal of cardiology
    79. DICKINSON LD; MILLER LD; PATEL CP; GUPTA SK
      ENOXAPARIN INCREASES THE INCIDENCE OF POSTOPERATIVE INTRACRANIAL HEMORRHAGE WHEN INITIATED PREOPERATIVELY FOR DEEP VENOUS THROMBOSIS PROPHYLAXIS IN PATIENTS WITH BRAIN-TUMORS

      Neurosurgery
    80. KRUPINSKI K; BIELAWIEC M; YOSHIDA K; KYOGASHIMA M; TAKADA Y; TAKADA A
      DERMATAN SULFATE ENHANCES THE LYSIS OF LASER-INDUCED THROMBUS IN-VIVO

      Thrombosis research
    81. Thilly, N; Pierson, H; Collard, C; Lecompte, T; Dufay, E
      Venous thromboembolism disease prophylaxis in medical patients: from medical decision tools to the use of low molecular weight heparins

      THERAPIE
    82. Berry, L; Stafford, A; Fredenburgh, J; O'Brodovich, H; Mitchell, L; Weitz, J; Andrew, M; Chan, AKC
      Investigation of the anticoagulant mechanisms of a covalent antithrombin-heparin complex

      JOURNAL OF BIOLOGICAL CHEMISTRY
    83. GENSINI GF; ROSTAGNO C; CACIOLLI S
      TREATMENT OPTIONS FOR ACUTE VERSUS THROMBOEMBOLISM IN THE OLDER PATIENT

      Geriatrics
    84. PHEKOO K; SCHEY S; HUNT BJ
      THE CURRENT USE OF LOW-MOLECULAR-WEIGHT HEPARINS IN CLINICAL-PRACTICE

      British Journal of Haematology
    85. BERGQVIST D
      MODERN ASPECTS OF PROPHYLAXIS AND THERAPY FOR VENOUS THROMBOEMBOLIC DISEASE

      Australian and New Zealand journal of surgery
    86. WHITE HD; ELLIS CJ; FRENCH JK
      LOW-MOLECULAR-WEIGHT HEPARINS IN ACUTE ISCHEMIC SYNDROMES

      Australian and New Zealand Journal of Medicine
    87. HABIS M; MORICE MC
      REVIEW OF CLINICAL-TRIALS OF ANTITHROMBOT ICS IN UNSTABLE ANGINA

      Annales de cardiologie et d'angeiologie
    88. SCHMIDT O; LANG W
      HEPARIN-INDUCED TYPE-II THROMBOCYTOPENIA - INTRAOPERATIVE AND POSTOPERATIVE LEPIRUDIN TREATMENT IN ACUTE-ISCHEMIA OF THE LEG

      Deutsche Medizinische Wochenschrift
    89. CAMPBELL MJ
      FOCUS ON DANAPAROID - A HEPARINOID FOR DVT PROPHYLAXIS WITH POTENTIALFOR USE IN HIT

      Formulary
    90. SKOUTAKIS VA
      DANAPAROID IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS

      The Annals of pharmacotherapy
    91. NEURAY M
      THROMBOPROPHYLAXIS AND EPIDURAL OR SPINAL -ANESTHESIA

      Infusionstherapie und Transfusionsmedizin
    92. CHESEBRO JH; RAUCH U; FUSTER V; BADIMON JJ
      PATHOGENESIS OF THROMBOSIS IN CORONARY-ARTERY DISEASE

      Haemostasis
    93. KAKKAR AK; WILLIAMSON RCN
      PREVENTION OF VENOUS THROMBOEMBOLISM IN CANCER USING LOW-MOLECULAR-WEIGHT HEPARINS

      Haemostasis
    94. PEREZREQUEJO JL; LUCENASOLANO O; PEREZGARCIA M; SANTARELLI MT
      VERY-LOW DOSES OF UNFRACTIONATED HEPARIN POTENTIATE THE ANTI-XA ACTIVITY OF LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN)

      Thrombosis research
    95. MCNALLY MA; COOKE EA; HARDING ML; MOLLAN RAB
      ATTITUDES TO, AND UTILIZATION OF, LOW-MOLECULAR-WEIGHT HEPARINS IN JOINT REPLACEMENT SURGERY

      Journal of the Royal College of Surgeons of Edinburgh
    96. WILDE MI; MARKHAM A
      DANAPAROID - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE IN THE MANAGEMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA

      Drugs
    97. INSLER SR; KRAENZLER EJ; BARTHOLOMEW JR; KOTTKEMARCHANT K; LYTLE B; STARR NJ
      THROMBOSIS DURING THE USE OF THE HEPARINOID ORGANON-10172 IN A PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA

      Anesthesiology
    98. KARAMANOS NK; VANKY P; TZANAKAKIS GN; TSEGENIDIS T; HJERPE A
      ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR DETERMINING DISACCHARIDE COMPOSITION IN HEPARIN AND HEPARAN-SULFATE

      Journal of chromatography
    99. MALSCH R; HARENBERG J; PIAZOLO L; HUHLE G; HEENE DL
      CHROMATOGRAPHIC AND ELECTROPHORETIC APPLICATIONS FOR THE ANALYSIS OF HEPARIN AND DERMATAN SULFATE

      Journal of chromatography B. Biomedical applications
    100. STABLES RH; SIGWART U
      POST-STENT MANAGEMENT WITH A PNEUMATIC GROIN COMPRESSION DEVICE AND SELF INJECTED LOW-MOLECULAR-WEIGHT HEPARIN

      HEART


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 22:30:47